Xerostomia - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Xerostomia - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Xerostomia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Xerostomia Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Xerostomia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Xerostomia outlook. It also includes the explanation of changing trends of epidemiology outlining the Xerostomia scenario.

Xerostomia Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Xerostomia thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Xerostomia Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Xerostomia

Key assessments

- Patient Segmentation in Xerostomia

- Xerostomia Risk & Burden

- Factors driving growth in a specific Xerostomia patient population

Xerostomia - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Xerostomia Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Xerostomia in 2016
2.2. Patient Share Distribution of Xerostomia in 2028
3. Disease Background and Overview: Xerostomia
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Xerostomia in 7MM
4.3. Total Prevalent/ Incident Patient Population of Xerostomia in 7MM - By Countries
5. Epidemiology of Xerostomia by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Xerostomia
5.1.3. Sub-Type Specific cases of the Xerostomia *
5.1.4. Sex- Specific Cases of the Xerostomia *
5.1.5. Diagnosed Cases of the Xerostomia
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Xerostomia
5.4.3. Sub-Type Specific cases of the Xerostomia *
5.4.4. Sex- Specific Cases of the Xerostomia *
5.4.5. Diagnosed Cases of the Xerostomia
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Xerostomia
5.5.3. Sub-Type Specific cases of the Xerostomia *
5.5.4. Sex- Specific Cases of the Xerostomia *
5.5.5. Diagnosed Cases of the Xerostomia
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Xerostomia
5.6.3. Sub-Type Specific cases of the Xerostomia *
5.6.4. Sex- Specific Cases of the Xerostomia *
5.6.5. Diagnosed Cases of the Xerostomia
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Xerostomia
5.7.3. Sub-Type Specific cases of the Xerostomia *
5.7.4. Sex- Specific Cases of the Xerostomia *
5.7.5. Diagnosed Cases of the Xerostomia
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Xerostomia
5.8.3. Sub-Type Specific cases of the Xerostomia *
5.8.4. Sex- Specific Cases of the Xerostomia *
5.8.5. Diagnosed Cases of the Xerostomia
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Xerostomia
5.9.3. Sub-Type Specific cases of the Xerostomia *
5.9.4. Sex- Specific Cases of the Xerostomia *
5.9.5. Diagnosed Cases of the Xerostomia
6. Unmet Needs of the Xerostomia
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Xerostomia in 7MM
Table 2: Total Prevalent/Incident Cases of the Xerostomia in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Xerostomia in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Xerostomia in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Xerostomia in United States (2016-2028)*
Table 6: Diagnosed Cases of the Xerostomia in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Xerostomia in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Xerostomia in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Xerostomia in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Xerostomia in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Xerostomia in France (2016-2028)
Table 12: Sub-Type Specific cases of the Xerostomia in France (2016-2028) *
Table 13: Sex- Specific Cases of the Xerostomia in France (2016-2028) *
Table 14: Diagnosed Cases of the Xerostomia in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Xerostomia in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Xerostomia in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Xerostomia in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Xerostomia in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Xerostomia in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Xerostomia in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Xerostomia in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Xerostomia in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Xerostomia in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Xerostomia in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Xerostomia in UK (2016-2028) *
Table 26: Diagnosed Cases of the Xerostomia in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Xerostomia in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Xerostomia in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Xerostomia in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Xerostomia in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Xerostomia in 7MM
Figure 2: Total Prevalent/Incident Cases of the Xerostomia in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Xerostomia in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Xerostomia in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Xerostomia in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Xerostomia in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Xerostomia in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Xerostomia in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Xerostomia in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Xerostomia in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Xerostomia in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Xerostomia in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Xerostomia in France (2016-2028) *
Figure 14: Diagnosed Cases of the Xerostomia in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Xerostomia in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Xerostomia in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Xerostomia in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Xerostomia in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Xerostomia in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Xerostomia in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Xerostomia in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Xerostomia in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Xerostomia in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Xerostomia in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Xerostomia in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Xerostomia in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Xerostomia in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Xerostomia in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Xerostomia in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Xerostomia in Japan (2016-2028)

  • Global Mouth Ulcer Treatment Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Mouth Ulcer Treatment Drug market size was valued at US$ 1574 million in 2023. With growing demand in downstream market, the Mouth Ulcer Treatment Drug is forecast to a readjusted size of US$ 2063.2 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Mouth Ulcer Treatment Drug market. Mouth Ulcer Treatment Drug are expected to show stable growth in the fu......
  • Global Mouth Ulcer Treatment Drug Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 159
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Mouth Ulcer Treatment Drug Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 137
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • 2023-2031 Report on Global Mouth Ulcer Treatment Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 104
    This report studies the Mouth Ulcer Treatment Drug market, covering market size for segment by type (Gel, Spray, etc.), by application (Hospitals, Clinics, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Colgate-Palmolive, Pfizer, GlaxoSmithKline, 3M Healthcare, Sannova, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Mouth Ulcer Trea......
  • Global Mouth Ulcer Treatment Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Feb-2023        Price: US 3260 Onwards        Pages: 112
    Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in the mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers are not contagious and usually go away within one to two weeks. The Mouth Ulcer Treatment Drug market revenue was 1335.52 Million USD in 2022, and will reach 1807.87 Million USD in 2028, with a CAGR of 5.18% during 2022-2028. This report elaborates the market size, market chara......
  • Mouth Ulcer Treatment Drug Market, Global Outlook and Forecast 2023-2029
    Published: 16-Jan-2023        Price: US 3250 Onwards        Pages: 119
    Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren't contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining go......
  • Global Mouth Ulcer Treatment Drug Market Research Report 2023
    Published: 07-Jan-2023        Price: US 2900 Onwards        Pages: 104
    Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren't contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining go......
  • Global Mouth Ulcer Treatment Drug Market Growth 2023-2029
    Published: 06-Jan-2023        Price: US 3660 Onwards        Pages: 111
    Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren't contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining go......
  • Global Mouth Ulcer Treatment Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 05-Jan-2023        Price: US 3450 Onwards        Pages: 100
    Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in the mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers are not contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as the dry mouth or substituting a problem me......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs